Cerebrasol Canada Ltd. specialises in the design and delivery of focussed preclinical research packages, using electrophysiological recording techniques for nervous system indications such as pain, neurodegeneration (Alzheimer’s and Parkinson’s disease), psychiatric disorders, movement disorders and obesity.
We prepare your compounds for clinical development by providing a flexible, highly skilled service with fast turnaround tailored to our clients’ needs, delivering key proof-of-concept, drug efficacy, mechanism of action data and more.
Cerebrasol Canada Ltd are located within the Neomed Institute, for further information please visit www.neomed.ca
Cerebrasol Canada Ltd is a contract research organisation (CRO) which was established to provide high quality highly specialised translational neuroscience research services to the biopharmaceutical industry. Our global clientele ranges from small, “start-up” biotechnology companies to major, multinational pharmaceutical establishments.